Novel Trypanosoma brucei dihyfrofolate reductase (DHFR) inhibitors from repurposing the medicines for malaria venture (MMV) pathogen box library

被引：0
|
作者：
Dize, Darline [3 ]
Tata, Rolland Bankar [1 ]
Keumoe, Rodrigue [3 ]
Kouipou, Rufin Marie Toghueo [3 ]
Tali, Mariscal Brice Tchatat [3 ]
Ngansop, Cyrille Armel Njanpa [3 ]
Tchuenguia, Claire Vianey [3 ]
Tsouh, Patrick Valere [3 ]
Laleu, Benoit [2 ]
Boyom, Fabrice [3 ]
机构：
[1] Rhodes Univ, Res Unit Bioinformat RUBi, Makana, South Africa
[2] Med Malaria Venture, Meyrin, Switzerland
[3] Univ Yaounde I, Lab Phytobiochem & Med Plants Study, Yaounde, Cameroon
来源：
TROPICAL MEDICINE & INTERNATIONAL HEALTH | 2023年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
115
引用
收藏
页码：89 / 90
页数：2
相关论文
共 15 条
  • [1] Screening a repurposing library, the Medicines for Malaria Venture Stasis Box, against Schistosoma mansoni
    Valérian Pasche
    Benoît Laleu
    Jennifer Keiser
    Parasites & Vectors, 11
  • [2] Screening a repurposing library, the Medicines for Malaria Venture Stasis Box against Schistosoma mansoni
    Pasche, Valerian
    Laleu, Benoit
    Keiser, Jennifer
    PARASITES & VECTORS, 2018, 11
  • [3] Preliminary Structure-Activity Relationship Study of the MMV Pathogen Box Compound MMV675968 (2,4-Diaminoquinazoline) Unveils Novel Inhibitors of Trypanosoma brucei brucei
    Dize, Darline
    Tata, Rolland Bantar
    Keumoe, Rodrigue
    Toghueo, Rufin Marie Kouipou
    Tchatat, Mariscal Brice
    Njanpa, Cyrille Ngansop
    Tchuenguia, Vianey Claire
    Yamthe, Lauve Tchokouaha
    Fokou, Patrick Valere Tsouh
    Laleu, Benoit
    Duffy, James
    Bishop, Ozlem Tastan
    Boyom, Fabrice Fekam
    MOLECULES, 2022, 27 (19):
  • [4] Temporal and Wash-Out Studies Identify Medicines for Malaria Venture Pathogen Box Compounds with Fast-Acting Activity against Both Trypanosoma cruzi and Trypanosoma brucei
    Sykes, Melissa L.
    Kennedy, Emily K.
    Read, Kevin D.
    Kaiser, Marcel
    Avery, Vicky M.
    MICROORGANISMS, 2022, 10 (07)
  • [5] Identification of Anti-staphylococcal and Anti-bio film Compounds by Repurposing the Medicines for Malaria Venture Pathogen Box
    Bhandari, Vasundhra
    Chakraborty, Shalini
    Brahma, Umarani
    Sharma, Paresh
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2018, 8
  • [6] Repurposing the Medicines for Malaria Venture's COVID Box to discover potent inhibitors of Toxoplasma gondii, and in vivo efficacy evaluation of almitrine bismesylate (MMV1804175) in chronically infected mice
    dos Santos, Bruna Ramos
    Ramos, Amanda Bruno da Silva Bellini
    de Menezes, Renata Priscila Barros
    Scotti, Marcus Tullius
    Colombo, Fabio Antonio
    Marques, Marcos Jose
    Reimao, Juliana Quero
    PLOS ONE, 2023, 18 (07):
  • [7] An Antiparasitic Compound from the Medicines for Malaria Venture Pathogen Box Promotes Leishmania Tubulin Polymerization
    Ullah, Imran
    Gahalawat, Suraksha
    Booshehri, Laela M.
    Niederstrasser, Hanspeter
    Majumdar, Shreoshi
    Leija, Christopher
    Bradford, James M.
    Hu, Bin
    Ready, Joseph M.
    Wetzel, Dawn M.
    ACS INFECTIOUS DISEASES, 2020, 6 (08): : 2057 - 2072
  • [8] Leishmania donovani Growth Inhibitors from Pathogen Box Compounds of Medicine for Malaria Venture
    Tadele, Markos
    Abay, Solomon M.
    Makonnen, Eyasu
    Hailu, Asrat
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 1307 - 1317
  • [9] Early Antischistosomal Leads Identified from in Vitro and in Vivo Screening of the Medicines for Malaria Venture Pathogen Box
    Pasche, Valerian
    Laleu, Benoit
    Keiser, Jennifer
    ACS INFECTIOUS DISEASES, 2019, 5 (01): : 102 - 110
  • [10] PfATP4 inhibitors in the Medicines for Malaria Venture Malaria Box and Pathogen Box block the schizont-to-ring transition by inhibiting egress rather than invasion
    Barnes, Claudia B. G.
    Dans, Madeline G.
    Jonsdottir, Thorey K.
    Crabb, Brendan S.
    Gilson, Paul R.
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12
12